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 1 
Abstract 21 
Herein, for the first time, we combined poly-L-Lactic acid (PLLA) with a strontium 22 
borosilicate bioactive glass (BBG-Sr) using electrospinning to fabricate a composite 23 
bioactive PLLA membrane loaded with 10 % (w/w) of BBG-Sr glass particles (PLLA-24 
BBG-Sr). The composites were characterised by scanning electron microscopy (SEM) 25 
and microcomputer tomography (μ-CT), and the results showed that we successfully 26 
fabricated smooth and uniform fibres (1 to 3 µm in width) with a homogeneous 27 
distribution of BBG-Sr microparticles (< 45µm). Degradation studies (in phosphate 28 
buffered saline) demonstrated that the incorporation of BBG-Sr glass particles into the 29 
PLLA membranes increased their degradability and water uptake with a continuous 30 
release of cations. The addition of BBG-Sr glass particles enhanced the membrane’s 31 
mechanical properties (69 % higher Young modulus and 36 % higher tensile strength). 32 
Furthermore, cellular in vitro evaluation using bone marrow-derived mesenchymal stem 33 
cells (BM-MSCs) demonstrated that PLLA-BBG-Sr membranes promoted the osteogenic 34 
differentiation of the cells as demonstrated by increased alkaline phosphatase activity and 35 
up-regulated osteogenic gene expression (Alpl, Sp7 and Bglap) in relation to PLLA alone. 36 
These results strongly suggest that the composite PLLA membranes reinforced with the 37 
BBG-Sr glass particles have potential  as an effective biomaterial capable of promoting 38 
bone regeneration. 39 
 40 
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1. Introduction 44 
The development of biomaterials for guided bone tissue engineering (BTE) has been a 45 
hot topic of research in recent years. Biomaterials can act as a short-term template in 46 
which cells proliferate and deposit extracellular matrix (ECM), helping bone ingrowth as 47 
a part of its regeneration process. A suitable biomaterial for BTE should present 48 
appropriate mechanical properties that is able to withstand the mechanical stress 49 
occurring at the lesion site and to support cell ingrowth as part of the bone formation 50 
process. The capacity to shape the biomaterial substrate to fit exactly in the bone lesion 51 
is of particular relevance, too [1, 2]. 52 
Electrospinning is a versatile technique that applies electrostatic forces to manufacture 53 
ultrathin fibre meshes from melted polymers or polymer solutions. This methodology has 54 
been used to obtain biomaterials composed by micro- or nano-fibres with high surface 55 
areas and mechanical properties suitable for BTE by playing with its different processing 56 
parameters [2, 3]. Furthermore, electrospun membranes closely mimic the ECM 57 
promoting cell attachment and proliferation [4]. 58 
Poly-L-lactic acid (PLLA) is a biodegradable and biocompatible polymer, widely 59 
investigated for BTE, specially due to the approval of different PLLA medical devices 60 
for clinical use by the US Federal Food and Drug Administration (FDA) [5]. Furthermore, 61 
PLLA has appropriate flexibility and deformation capacity, and can be processed by 62 
different techniques (e.g. melt, dry and wet spinning, as well as electrospinning) [6-9]. 63 
However, PLLA is not commonly considered osteoinductive [4, 10]. Thus, in order to 64 
improve the biological performance of PLLA fibres, the polymeric matrix can be 65 
combined with inorganic materials, such as bioactive glasses (BG) and glass-ceramics, 66 
improving its osteoinductive potential [11, 12]. Moreover, the PLLA degradation rate can 67 
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be shaped by several different variables (e.g. chemical structure and crystallinity of the 68 
polymer, size and shape of the final material), although, the matching of the rate of 69 
degradation and the kinetics of the formation of new bone tissue is still difficult to achieve 70 
[13, 14]. The addition of an inorganic phase allows a better control of the degradation rate 71 
of the final PLLA-glass composite, which can be used to manufacture a composite with 72 
a suitable degradation rate while progressively being substituted by the new bone that is 73 
being formed [15]. 74 
Bioactive glasses (BGs) are a group of inorganic bioactive materials that are able to form 75 
a bone-like hydroxyapatite (HA) layer on their surface capable to strongly bond to hard 76 
and soft tissues [11, 16-18]. Immediately after the launch of the 45S5 Bioglass® in the 77 
market (chemical composition by mol: 0.45SiO2  0.06P2O5  0.245Na2O  0.245CaO) it 78 
became the gold standard for bioactive glass materials [16]. Subsequently, a wide range 79 
of BGs based on the 45S5 composition have been developed and studied for BTE [19, 80 
20]. The addition of borate glass forming units is one approach that has potential to lower 81 
melting temperatures while controlling bio-degradation and increasing conversion rates 82 
to HA [21, 22]. Borosilicate-based BGs (BBGs) have previously been studied as 83 
biomaterials and have shown relevant capacity as osteointegrative antibacterial materials 84 
to be used in BTE [23, 24]. BBGs have been also incorporated into scaffolds: Wang et al. 85 
[25] successfully incorporated copper doped borosilicate glasses (BBG-Cu) into a 86 
polymeric scaffold for tissue engineering purposes. They observed an improvement in the 87 
stability of the glass network and the BBG-Cu promoted the angiogenesis in rat calvarial 88 
defects. 89 
Moreover, in our previous studies we tested a BBG glass composition (e.g. molar ratio: 90 
BBG-Sr: 0.05Na2O  0.35SrO  0.20B2O3  0.40SiO2) for their osteogenic capacity. We 91 
found that the presence of BBG-Sr glass particles improved the osteogenic differentiation 92 
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of bone marrow mesenchymal stem cells (BM-MSCs) and induced also the formation of 93 
mineralised tissue. We also demonstrated that demonstrated that BBG-Sr, at 94 
concentrations ≥ 18 mg/mL it was able to eradicate Pseudomonas aeruginosa bacterium 95 
[26]. Numerous reports have already associated Sr2+ with bone therapeutic potential [19]. 96 
Depending on the concentration Sr2+ can exerts many effects on bone metabolism at the 97 
tissue and cellular levels as well as in bone formation in vivo [27, 28]. For instance, Marie 98 
et al. [27] demonstrated strontium modulates bone cell function (e.g. cell proliferation 99 
and differentiation)  in vitro stimulating bone formation and inhibiting bone resorption. 100 
Moreover, Hesaraki et al. showed that glasses doped with Strontium promoted osteoblast 101 
proliferation and ALP activity when directly in culture with cells [29]. For instance, Wu 102 
et al. [30] developed a strontium silicate glass which promoted a high ALP activity in 103 
BM-MSC cell culture, which was associated with the release of Sr2+ and silica. Also, 104 
Santocildes-Romero et al. [31] demonstrated that strontium-substituted bioactive glasses 105 
promoted osteogenic differentiation of BM-MSCs cultures in the presence of strontium -106 
containing BGs. They showed an increased expression of genes such as Alpl and Bglap. 107 
Moreover, Gentleman et al. [32] studied the effect of the release of Si- and Sr-related 108 
chemical entities from PCL-SrBG scaffolds, and they detected that the SrBG particles 109 
stimulated osteoblast proliferation and ALP activity in relation to the SrBG-free PCL 110 
scaffold. Moreover, BM-MSCs are of special interest due to their capacity to 111 
differentiation into different lineages (including osteoblastic cells) with appropriate 112 
external stimuli and the fact that it is relatively easy to isolate [33]. For that reason, BM-113 
MSCs have received extensive attention as promoters of tissue regeneration. 114 
To our knowledge, the PLLA-BBG-Sr composite membranes fabricated by 115 
electrospinning has not been achieved to-date. Therefore, we aimed to evaluate the 116 
potential of PLLA-BBG-Sr composite membranes for BTE and bone regeneration. 117 
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Herein, we investigated the impact of the incorporation of BBG-Sr glass particles in 118 
PLLA fibre meshes on their tensile strength and degradation. Moreover, we evaluated the 119 
response of BM-MSCs in the presence of PLLA-BBG-Sr fibres, namely in what regards 120 
their morphology, proliferation and ability to induce its differentiation. 121 
2. Experimental 122 
2.1. Materials 123 
All chemicals used for the melt-quenched synthesis were reagent grade: boron oxide 124 
(B2O3, Alfa Aesar, Germany), calcium carbonate (CaCO3, Sigma-Aldrich, UK), sodium 125 
bicarbonate (NaHCO3, Sigma-Aldrich, Australia), silica gel 60M (SiO2, Macherey-126 
Nagel, Germany), magnesium oxide (MgO, Sigma-Aldrich, UK) and strontium carbonate 127 
(SrCO3, Sigma-Aldrich, Australia). All the chemical reagents used for electrospinning 128 
were reagent grade: PLLA with a L-lactide content of 99.6 % and an average Mw of 129 
69,000 g.mol-1 (Cargill Dow LLC, USA), dichloromethane (Sigma-Aldrich, UK), and the 130 
anionic surfactant docusate sodium salt (Sigma-Aldrich, UK). 131 
The BBGs were produced as described elsewhere. Briefly, the appropriate amounts of 132 
SiO2, B2O3, NaHCO3, and CaCO3 or MgO or SrCO3, were accurately mixed with ethanol 133 
(Sigma, Portugal) in a porcelain pestle and mortar, fully dried overnight and transfer to a 134 
platinum crucible (ZGS platinum, Johnson Matthey, UK). Each batch (~ 50 g) was heated 135 
to 1450 ºC in air for 1 hour and, subsequently, the melt was quickly poured into an ice-136 
water bath at ~ 0 ˚C to form a glass frit. Afterwards, the glasses of general formula 137 
0.05Na2O  xMgO  yCaO  (0.35-x-y)SrO  0.20B2O3  0.40SiO2 (molar ratio, where x, y 138 
= 0.35 or 0.00, and x ≠ y) were ground into an Agate mortar (RETSCH, Germany) to 139 
obtain microparticles and sieved to a size <45 μm to be homogeneously incorporated in 140 
the polymeric matrix during the fabrication of the fibres. The density of the BBGs was 141 
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measured by a Multi pycnometer (Quantachrome Instruments, USA) under helium at 142 
110 °C using ~ 5 g of each sample. 143 
2.2. Glasses synthesis and membranes preparation 144 
Electrospinning. PLLA-BBG-Sr membranes were fabricated inside a fume hood cabinet 145 
for safe solvent evaporation and in order to prevent that the turbulent air interferes in the 146 
formation of the fibres. The PLLA concentration, the ratio of PLLA/ BBG-Sr and the 147 
process parameters (e.g. applied voltage, flow rate and distance from the collector) were 148 
optimized in order to obtain uniform membrane of fibres. The final electrospun 149 
membranes were fabricated using PLLA dissolved in dichloromethane (16 % w/v) where 150 
the BBGs microparticles were suspended (10 % w/w BBGs/PLLA). Docusate sodium salt 151 
(1.2 % w/w relative to PLLA) was used to help the homogenization of the solution 152 
avoiding the formation of agglomerates. The PLLA and PLLA-BBG-Sr solutions were 153 
stirred overnight and sonicated 5 min before use to remove air bubbles. The set up was 154 
mounted using a high voltage supplier, a syringe pump (Baxter AS50) with a 20 gauge 155 
metal needle (Fisnar, New Jersey, USA) and a conductive collector. The PLLA and 156 
PLLA-BBG-Sr solutions were drawn up into a 1 ml syringe (BD Plastipak, New Jersey, 157 
USA). The solutions were electrospun using 17 kV and a flow rate of 3 mL/h at a 19 cm 158 
distance between the collector and needle. The electrospun membranes were dried in a 159 
fume hood, at room temperature, for 24 h, collected and stored in a desiccator at room 160 
temperature. 161 
2.3. Characterisation of electro-spun membranes 162 
2.3.1. Scanning electron microscopy (SEM) 163 
The Scanning Electron Microscopy (Leica Cambridge S360 microscope, equipped with 164 
an energy dispersive spectrometer, UK) was used to assess the surface morphology of the 165 
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fabricated PLLA and PLLA-BBG-Sr membranes. Prior to the analysis, all the scaffolds 166 
were sputter-coated with gold. The micrographs were acquired using a beam energy of 167 
5.0kV and working distance (WD) of ~ 5.2 mm. 168 
2.3.2. Micro-computed tomography (µCT) 169 
Micro-computed tomography (µ-CT) was carried out on a high-resolution µ-CT scanner 170 
(SkyScan1272, Bruker, Kontich, Belgium), using a pixel size of 9.8 µm and integration 171 
time of 160 ms. The X-ray source was set at 50 kV of energy and 200 µA of current. 172 
Approximately 400 projections were acquired over a rotation range of 180° with a 173 
rotation step of 0.60°. Data sets were reconstructed using standardised cone-beam 174 
reconstruction software (NRecon v1.6.10.2, SkyScan). The output format for each sample 175 
was a series of 601 bitmap images (1224 × 1224 pixels). 3D virtual models of 176 
representative regions in the bulk of the scaffolds were created applying colour channel 177 
thresholds and visualised using an image processing software (CTvox). 178 
2.3.3. Mechanical tests 179 
Tensile strength and modulus of the PLLA and PLLA-BBG-Sr membranes were 180 
measured using a Uniaxial Universal Testing Machine (Instron 4505, USA) according to 181 
the standard ASTM D 638. The membranes were cut into strips of 50 mm length, 10 mm 182 
width and 0.1 mm thickness. The tests were conducted using a 1 kN load cell, with a 183 
gauge length of 20 mm and a crosshead speed of 5 mm.min-1 until rupture. The tensile 184 
force was taken from the stress-strain curves as the maximum stress hold by the samples. 185 
Tensile modulus was estimated from the initial slope of the stress–strain curve (between 186 
0.5 % and 1 % strain) using the linear regression method. The average and standard 187 
deviations were determined using 5 specimens per composition. 188 
2.3.4. Degradation assay 189 
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The electrospun membranes (n= 3 per time point) were immersed in PBS (Sigma-Aldrich, 190 
UK) at a ratio of 10:10 (membrane (mg): PBS (mL)) for 7, 14, 21, and 28 days in a water-191 
shaking bath at 60 rpm and 37 °C. Each immersion solution was filtered and the pH 192 
measured (Crison Instruments, Spain). Inductive coupled plasma (ICP) analysis was 193 
performed to determine the concentrations of Si, B and Sr in solution. The absorption was 194 
measure at specific wavelengths (λ= 251.611 nm for Si, λ= 249.773 nm for B and λ= 195 
407.771 nm for Sr) and the concentrations were determined using calibration curves 196 
obtained with standard solutions (Alfa Aesar) prior to the analysis of the samples. 197 
The membranes were removed from PBS, the excess surface water was removed and the 198 
samples were immediately weighed. Afterwards, the samples were dried in the oven at 199 
37 °C, to constant weight, recording the final mass of the membranes. The water uptake 200 
(WU) was calculated according to Eq. (1): 201 
𝑊𝑈(%) = (𝑚𝑡𝑝 − 𝑚𝑓) 𝑚𝑓 ⁄ × 100    Eq. (1) 202 
Where mtp is the wet mass of the specimen at the specific time (days), and mf is the final 203 
mass after immersion and drying. The weight loss (WL) was calculated according to Eq. 204 
(2): 205 
𝑊𝐿(%) = (𝑚𝑓 − 𝑚𝑖 ) 𝑚𝑖 ⁄ × 100    Eq. (2) 206 
Where mf is the mass of the dried membranes after its immersion in water, and mi is the 207 
mass of the dried membranes before immersion in PBS. 208 
Thermogravimetric analysis (TGA; Q500, TA Instruments, USA) was also used to 209 
quantify the changes in the weight (mass) of the membranes during the degradation 210 
process. In addition, thermal analysis was performed to determine the amount of BBG-Sr 211 
(non-combustible) glass particles that was compounded with PLLA to produce the 212 
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composite membranes. Experiments were performed in platinum pans, at a heating rate 213 
of 40 kmin-1 from 50 to 700 °C in an oxygen atmosphere. 214 
2.4. In vitro culture of BM-MSCs on electrospun membranes 215 
2.4.1. Isolation and expansion of BM-MSCs 216 
Bone marrow mesenchymal stem cells (BM-MSCs) were isolated from bone marrow of 217 
4-5 week-old male Wistar rats according to the method established by Maniatopoulos et 218 
al. [34] and recently used by by Santocildes-Romero [31]. BM-MSCs were expanded in 219 
basal medium consisting of Dulbecco’s modified Eagle’s medium (DMEM; Sigma-220 
Aldrich, UK), supplemented with 100 U/mL penicillin (Sigma-Aldrich, UK) and 100 221 
µg/mL streptomycin (Sigma-Aldrich, UK). Cells were cultured at 37 ºC in an atmosphere 222 
of 5 % CO2. 223 
2.4.2. Culture of BM-MSCs 224 
Prior to the in vitro studies, BM-MSCs, at passage 2, were harvested and seeded at a 225 
density of 3×104 cells per membrane of Ø = 6.5 mm held in plastic inserts (CellCrown™ 226 
24, Scaffdex, UK). Cells were cultured for 7, 14 and 21 days under static conditions. All 227 
scaffold conditions were cultured in basal and osteogenic differentiation media (basal 228 
medium supplemented with 50 µg/mL L-ascorbic acid, 10 mM β-glycerophosphate and 229 
10-8 M dexamethasone). 230 
2.4.3. BM-MSCs proliferation, viability and morphology 231 
Morphological evaluation of cultured cells: After each time-point the cells cultured on 232 
the membranes were washed with PBS and fixed with 4% formalin solution (0.5 mL) for 233 
15 min at room temperature (RT). The cells were then washed with PBS, containing 0.2 234 
% Triton X, for 2 min. After the fixation and permeation steps, the cells were washed 235 
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again with PBS and stained with 4,6-diamidino-2-phenyindole dilactate (1:1000 DAPI, 236 
Sigma-Aldrich, UK) for 2 min at RT, and phalloidin-tetramethylrhodamine B 237 
isothiocyanate (Sigma-Aldrich, UK) for 1 h at RT. Finally, the cells were washed and 238 
observed using an Axioplan 2 imaging fluorescent microscope with a digital camera QIC 239 
AM 12-bit (Zeiss, UK). 240 
Cell viability and proliferation (PrestoBlue® and PicoGreen® assays). The 241 
PrestoBlue® reagent (Fisher Scientific, UK) is a resazurin-based solution that is reduced 242 
to resorufin by viable cells which can be detected flurometrically.  The cell viability assay 243 
was executed according to the manufacturer’s instructions. In brief, the PrestoBlue® 244 
reagent was added to a final concentration of 10 % to the cell culture medium and the 245 
cultures incubated for 1 h at 37 oC. 200 µL samples of the culture medium were removed 246 
and placed in 96-well plates and the resorufin fluorescence quantified 247 
spectrophotometrically using a plate reader (Tecan Infinite M200). The fluorescence was 248 
determined at an excitation wavelength of 560 nm and emission wavelength of 590 nm. 249 
The metabolic activity was presented in fluorescence values and compared with the 250 
control (cell cultured onto PLLA membranes under basal medium conditions). 251 
The PicoGreen® dsDNA reagent (Invitrogen, USA) is an ultrasensitive fluorescent 252 
nucleic acid dye for quantification of double-stranded DNA (dsDNA) in solution. This 253 
assay enables measurement of cell proliferation. After each culturing period, the cells 254 
were washed with PBS and incubated at 37 ºC for 3 h followed by a freezing step at -80 255 
ºC for overnight in ultra-pure water (1 mL) to ensure the cell lysis. Finally, the 256 
fluorescence was determined at an excitation wavelength of 485 nm and emission 257 
wavelength of 528 nm. The DNA concentration was presented in µg/mL and compared 258 
with the control (cell cultured onto PLLA membranes under basal medium conditions). 259 
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2.4.3. Alkaline phosphatase quantification 260 
The concentration of alkaline phosphatase (ALP) was determined for all the cell culture 261 
time points, using the lysates used for the DNA quantification and the Alkaline 262 
Phosphatase, Diethanolamine Detection kit (Sigma-Aldrich, UK), which is based on the 263 
conversion of p-nitrophenyl phosphate (pNPP) to free p-nitrophenol by ALP. In brief, a 264 
buffered pNPP solution was prepared and equilibrated at 37 ºC. Afterwards, 2 % (v/v) of 265 
sample or control lysate was added. Immediately after mixing the absorbance was read at 266 
405 nm in a plate reader (Tecan Infinite M200) for ≈ 5 min. An ALP standard solution 267 
was used as control and buffer as blank. The units were calculated according to the 268 
following Eq. (3): 269 
(∆𝑨𝟒𝟎𝟓𝒏𝒎/ 𝐦𝐢𝐧  𝑻𝒆𝒔𝒕−∆𝑨𝟒𝟎𝟓𝒏𝒎/ 𝐦𝐢𝐧 𝑩𝒍𝒂𝒏𝒌)×𝒅𝒇×𝑽𝑭
𝟏𝟖.𝟓×𝑽𝑬
    Eq. (3) 270 
Where df = dilution factor; VF = Volume of final solution; 18.5 = millimolar extinction 271 
coefficient of pNPP at 405 nm and VE = Volume of samples/ALP standard solution. 272 
2.4.4. RNA isolation and real-time quantitative polymerase chain reaction (rtPCR) 273 
RNA was extracted with Tri-reagent (Sigma-Aldrich, UK) according to the 274 
manufacturer's instructions. The RNA concentration was determined by 275 
microspectrophotometry (NanoDrop 1000). The cDNA synthesis was performed using 276 
the qScript cDNA synthesis kit (Quanta BioSciences, VWR) with 100 ng of RNA 277 
template in a final volume of 20 μL. Cycling was as follows: 1 cycle at 22 °C, 5 min; 1 278 
cycle at 42 °C, 30 min; 1 cycle at 85 °C, 5 min. The amplification of the target cDNA 279 
was performed using the PerfeCTa SYBR Green FastMix (Quanta BioSciences) with 1 280 
μL of cDNA, 200 nM of each primer (Table 1) in a final volume of 20 μL. Real time-281 
PCR cycling was as follows: 1 cycle at 95 °C, 2 min; 44 cycles at 95 °C; 10 s at gene 282 
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annealing temperature (Table 1); 30 s at 72 °C; followed by dissociation curve analysis. 283 
All the reactions were carried out on a PCR cycler Mastercycler Realplex (Hamburg, 284 
Germany). The transcripts expression data were normalized to the housekeeping gene 285 
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) in each sample. The quantification 286 
was performed according to the Livak method (2−ΔΔCt method [35]), considering as 287 
calibrator at each time point the PLLA - basal medium for PLLA- osteogenic medium 288 
and PLLA-BBG-Sr basal medium for PLLA-BBG-Sr osteogenic medium (threshold = 289 
1). 290 
Table 1. Primers used for qPCR 291 
Gene Primer sequence 5’-3’ Forward/ reverse Tm (ºC) 
Osteocalcin (Bglap) CATCTATGGCACCACCGTTT 60.0 
  AGAGAGAGGGAACAGGGAGG  
Osteopontin (Spp1) ATCTCACCATTCCGATGAATCT 60.0 
 CAGTCCATAAGCCAAGCTATCA  
Osterix (Sp7) CACTGGCTCCTGGTTCTCTC 60.0 
 CCACTCCTCCTCTTCGTGAG  
Alkaline phosphatase (Alpl) TGCCTTACCAACTCATTTGTG 57.4 
 ACGCGATGCAACACCACTC  
 292 
3. Results and discussion 293 
3.1. Characterisation of electrospun membranes 294 
The PLLA and PLLA-BBG-Sr (10 % w/w BBG-Sr/PLLA) composite membranes were 295 
successfully obtained by electrospinning. TGA analysis confirmed that we successfully 296 
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incorporated 10 % (w/w) of BBG-Sr microparticles in the PLLA fibres. The morphology, 297 
microstructure and fibre integrity of the electrospun PLLA and PLLA-BBG-Sr 298 
membranes was characterised by scanning electron microscopy (SEM) and µCT. 299 
Electrospun PLLA and PLLA-BBG-Sr membranes are composed of smooth and uniform 300 
fibres. No large particles were detected (Figure 1a and 1c), however, the formation of 301 
small agglomerates in the membranes containing the BBG-Sr microparticles was 302 
observed [36]. Figure 1c highlights in red circles the BBG-Sr microparticles incorporated 303 
into the fibres. The homogeneous distribution of the BBG-Sr microparticles in the PLLA-304 
BBG-Sr membrane could be observed in the 2D virtual model representatively obtained 305 
using an image processing software CTvox of µCT images (Figure 1d), in which the red 306 
colour represents the BBG-Sr microparticles distributed into the composite membranes 307 
in green. As expected, the PLLA membranes do not present any particles in their structure 308 
(Figure 1b). 309 
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 310 
Figure 1. SEM micrographs (a and c) and representative µCT 2D images (b and d) of 311 
PLLA and PLLA-BBG-Sr membranes. The areas encompassed by red lines in (c) show 312 
particles incorporated into the fibres. In (b and d) PLLA fibres are represented in green 313 
and the BBG-Sr microparticles are represented in red. 314 
The mechanical properties of the biomaterials are important in providing physical support 315 
for cell growth and migration matching those of the tissue at the site of implantation [37]. 316 
Figure 2a presents the stress–strain curves obtained for the PLLA and PLLA-BBG-Sr 317 
membranes under tensile load up to a strain of 50 %. The PLLA-BBG-Sr membranes 318 
showed the highest tensile strength (0.75 ± 0.7 MPa), when compared to the PLLA 319 
membranes (0.55  ± 0.6MPa), indicating that the incorporation of BBG-Sr reinforced the 320 
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membranes. The same trend was observed for the Young’s modulus (Figure 2b), 321 
calculated from the initial linear slope of the stress-strain curves, where the loading of 322 
BBG-Sr microparticles improved the modulus from 14.6 ± 3.8 MPa (PLLA) to 24.7 ± 5.3 323 
MPa (PLLA-BBG-Sr). This might be due to an increase in rigidity through the filler 324 
effect, in which the microparticles encumber the movement of the polymer chains and the 325 
amount of extendable material in the membrane. On the other hand, while the 326 
incorporation of the microparticles in PLLA-BBG-Sr membranes can affect the tensile 327 
strength, where there is no interaction between fibres and particles. The availability of 328 
cations derived from the incorporated microparticles may contribute to the crosslinking 329 
of the carboxylic acid groups (that are present in the chain ends of the PLLA) through the 330 
formation of carboxylates with the cations released from the microparticles. These 331 
carboxylate cross-links induce the interlocking of the membranes, resulting in an 332 
improvement of the Young modulus [38] As demonstrated by Thomas et al. [39], small 333 
concentrations of nano hydroxyapatite (HA) resulted in a reinforcement of PCL. It was 334 
observed by Jeong et al. [40] in an analogous way that the addition of increasing 335 
concentrations of HA increasingly enhanced the mechanical properties of the composite, 336 
namely their tensile strength and Young’s modulus. Therefore, our results support that, 337 
with the inclusion of BBG-Sr microparticles into the PLLA matrix, it is possible to tune 338 
their mechanical properties, contribution to be a closer match of those from the living 339 
tissue at the site of implantation. 340 
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 341 
Figure 2. (a) Stress–strain curves of PLLA and PLLA-BBG-Sr membranes and their 342 
respective (b) Young's modulus determined from the initial slope of the curves. The data 343 
was analysed by non-parametric statistics: Mann-Whitney test revealed a significance of 344 
p<0.05 (*). 345 
 346 
3.2. Degradation of the electrospun membranes 347 
A biomaterial suitable for promoting bone regeneration in a tissue engineering 348 
perspective should present an appropriate biodegradability. The BTE concept is based on 349 
the substitution of the biomaterial by new bone. This requires that the degradation rate of 350 
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the biomaterial matches that of new bone formation, in order to occur a progressive 351 
substitution of the biomaterial by the new bone tissue [15, 41]. The degradation profiles 352 
of PLLA and PLLA-BBG-Sr membranes (Figure 3) were evaluated from the weight loss 353 
and water uptake, as well as the release of chemical species from the membranes and pH 354 
of the immersion solutions. The water uptake and weight loss data showed differences 355 
between the PLLA and the PLLA-BBG-Sr membranes (Figure 3a and b). Both 356 
membranes presented steady and continuous water uptake and weight loss from week 2 357 
to week 3. However, the PLLA-BBG-Sr membranes presented a more pronounced ‘burst’ 358 
of weight loss during the first week. The differences between the two membranes during 359 
this initial stage of degradation might be attributed to the penetration of the PBS solution 360 
through the polymer/glass interface and/or surface cracks that facilitated the degradation 361 
of the material and enhanced the water uptake. Another possibility is related with a 362 
superficial hydrolytic degradation generated by the leaching of chemical species from the 363 
glass particles [42, 43]. The pH measurements presented no significant variation of pH 364 
for both PLLA and PLLA-BBG-Sr membranes over time. It was observed an increasing 365 
release of B, Si and Sr from the PLLA-BBG-Sr membranes over time of immersion 366 
(Figure 3c). The release of such chemical species can only be originated from the BBG-367 
Sr microparticles, confirming that the weight loss is mainly caused by the hydrolytic 368 
degradation of the glass particles. During the last week of degradation (21 to 28 days) it 369 
was also noticed an increase in the PLLA-BBG-Sr weight loss that is in line with the 370 
reduction of glass content as determined by TGA tests (Figure 3d) and the increased 371 
concentration of mainly B and Sr-containing chemical species, that were leached from 372 
the glass particles to the immersion medium (detected by ICP). The increase on the 373 
degradation is clear during the last week; however, the leaching observed by ICP during 374 
the first 3 weeks is not corroborated by the TGA analysis. In this case, the presence of 375 
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phosphates from the solution buffer might generate a surface layer of strontium phosphate 376 
that limits the mass exchange from the glass particles to the immersion solution. In this 377 
case, the weight loss derived from the leaching of B, Si and Sr from the glass particles is 378 
partially compensated by the deposition of phosphates. The fact that the PLLA-BBG-Sr 379 
composite membranes lost twice the mass during the degradation process suggests that 380 
the incorporation of BBG-Sr into PLLA fibres increased the degradability and the 381 
degradation rate of the membranes, as well as the release of active chemical species to 382 
the surrounding medium [15]. 383 
 384 
Figure 3. Degradation profile of the PLLA and PLLA-BBG-Sr membranes during 30 day 385 
of degradation in PBS at 37 ºC. (a and d) WU and WL of the PLLA and PLLA-BBG-Sr 386 
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membranes; (c) release profiles of chemical species from the PLLA-BBG-Sr membranes; 387 
and (d) percentage of glass (w/w) in the studied membranes. 388 
 389 
3.3. In vitro biological evaluation 390 
Morphology, viability and proliferation of the BM-MSCs 391 
Apart from the suitable chemical and physical properties of the biomaterial, it is also 392 
crucial to evaluate if theyare cytotoxic.. To this purpose, direct contact assays are widely 393 
used as a preliminary screening for biomaterials [44]. Fluorescence microscopy images 394 
(Figure 4a) show the morphology of BM-MSCs cultured in the presence of PLLA and 395 
PLLA-BBG-Sr membranes in basal or osteogenic medium (Figure 4a, Basal and Osteo, 396 
respectively). The attached BM-MSCs displayed a well-spread morphology and several 397 
cell-to-cell contacts. As expected, the PrestoBlue® and PicoGreen® data (Figure 4b and 398 
4c) demonstrated that the cells proliferated over the time course under basal conditions, 399 
which is consistent with the morphology images (Figure 4a). There is also and increase 400 
on their metabolic activity (day 7 versus day 21). However, under osteogenic conditions 401 
BM-MSCs did not proliferate and exhibited an increase inmetabolic activity (day 7 versus 402 
day 21), which suggested the occurrence of differentiation [8, 45]. PLLA and PLLA-403 
BBG-Sr electrospun membranes were found to be a non-cytotoxic support for BM-MSCs 404 
attachment and proliferation (Figure 4) without any adverse effect caused by the addition 405 
of BBG-Sr particles. Inaddition, the randomly distributed fibres and porous structure of 406 
electrospun membranes should enable an efficient transfer of nutrients, as well as support 407 
suitable cell penetration into the bulk of the membranes. 408 
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 409 
Figure 4. (a) Morphology, (b) metabolic activity and (c) proliferation of BM-MSCs 410 
cultured for 7, 14 and 21 days in basal (basal) or osteogenic medium (osteo), and in the 411 
presence of PLLA or PLLA-BBG-Sr. In the representative microscopy images (a) the 412 
nuclei of cells are stained in blue (DAPI) and the actin filaments are stained in green 413 
(Phalloidin). In Figure 4b and 4c, the results are expressed as means ± standard deviation 414 
with n = 3 for each experimental data point. The data were analysed by non-parametric 415 
statistics: Kruskal-Wallis test, followed by a Dunn’s Multiple Comparison test and were 416 
marked as: *** p<0.001; **p<0.01; * p<0.05. On the graphs the figure ‘1’ represents the 417 
comparison with day 7 and the figure ‘2’ represents the comparison with day 14. 418 
3.3. Osteogenic differentiation markers 419 
It has been demonstrated that the release of chemical species containing Si, B or Sr from 420 
BBG-Sr glass particles could stimulate the osteoblast proliferation and differentiation. 421 
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The ALP activity is commonly related with functional activity of the bone-derived cells, 422 
such as their osteogenic differentiation and the onset of mineralisation [36, 46]. In order 423 
to execute a preliminary evaluation on the capacity of the PLLA-BBG-Sr membranes to 424 
induce osteogenic differentiation, we cultured BM-MSCs onto them and quantified the 425 
ALP activity after 7, 14 and 21 days (Figure 5b). SEM was also used to check for mineral 426 
deposits and the mineralisation stage of the BM-MSCs (Figure 5a). In the SEM 427 
micrographs it is possible to confirm that the BM-MSCs create a cell layer attached to the 428 
PLLA and PLLA-BBG-Sr membranes. However, in the case of BM-MSCs cultured under 429 
osteogenic conditions, formation of phosphate deposits at the later time points (Figure 430 
5a, day 21) were observed. In contrast, ALP activity (Figure 5b) increased during the 431 
time of culture under osteogenic conditions, suggesting that the addition of BBG-Sr 432 
microparticles increased the ALP expression levels. Therefore, the PLLA-BBG-Sr 433 
membranes stimulated the BM-MSCs to initiate their osteogenic differentiation. This 434 
stimulus is very likely to be related with the presence of the B, Si and Sr chemical species 435 
leaching from the BBG-Sr glass particles to the surrounding medium [47, 48], as also 436 
shown in the ICP data (Figure 3a). Comparatively, some authors [31, 32] studied the 437 
effect of the release of Si and Sr chemical species from BG, and found that they stimulate 438 
cell differentiation. Other authors have also demonstrated improvements in cell 439 
differentiation and bone mineralisation by the addition of glass particles into polymeric 440 
matrices [6, 36, 49]. As an example, Santocildes-Romero [9], fabricated electrospun 441 
membranes incorporating 10% BGSr glass particles with increasing Sr composition with 442 
no cytotoxic effects on at osteosarcoma cells; Rajzer and co-workers [36] verified that 443 
the addition of 20% hydroxyapatite ceramic particles into PLDL electrospun composites 444 
could direct HAp mineralisation in cell culture; Ren et al. [6] also showed that PCL-SrBG 445 
electrospun scaffolds enhanced the ALP activity of MC3T3-E1 cells in the presence of 446 
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osteogenic media in comparison with the glass-free PCL scaffolds after 21 days of 447 
culture. Hence, the addition of BBG-Sr glass particles to PLLA fibres accelerates the BM-448 
MSCs osteogenic differentiation (ALP activity, Figure 5a), in the presence of osteogenic 449 
media after 14 days of cell culture, showing an higher increase after 21 days of cell 450 
culture. 451 
 452 
Figure 5. (a) Morphology/mineralisation (SEM micrographs) of BM-MSCs and their (b) 453 
ALP activity after 7, 14 and 21 days of culture in the presence of PLLA and PLLA-BBG-454 
Sr, in basal (basal) or osteogenic medium (osteo). ALP results are expressed as mean ± 455 
standard deviation with n = 3 for each datapoint. The data was analysed by non-parametric 456 
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statistics: Kruskal-Wallis test, followed by a Dunn’s Multiple Comparison test. ** 457 
(p<0.01); * (p<0.05). The significance is in relation to cells cultured on PLLA (in the 458 
absence of BBG-Sr glass particles) under the same culture conditions. 459 
 460 
Complementary to the reported viability, proliferation and ALP activity data, the 461 
differentiation level of BM-MSCs cultured onto PLLA and PLLA-BBG-Sr membranes 462 
was assessed by quantitative PCR of selected bone-specific gene transcripts. In the 463 
literature it is well described that osteogenic differentiation of BM-MSCs has three 464 
phases: the proliferative phase, which is followed by the ECM synthesis and maturation, 465 
and lastly the mineralisation phase [50, 51]. Therefore, in this study the osteogenic 466 
potential of the cells was evaluated at day 14 and 21 using the expression pattern of the 467 
representative osteogenic markers: Alpl, Spp1, Bglap and Sp7 [8, 52]. The transcripts 468 
expression data were normalized against the housekeeping gene Gapdh and the 469 
quantification performed according to the Livak method (2-ΔΔCt method), considering the 470 
PLLA (basal medium) as calibrator for PLLA (osteogenic medium) and PLLA-BBG-Sr 471 
(basal medium) as calibrator for PLLA-BBG-Sr (osteogenic medium). Commonly, Alpl 472 
acts as early marker of the osteoblastic phenotype. This gene expression level is known 473 
to increase with the progression of osteoblastic differentiation [53]. According to the gene 474 
expression data (Figure 6a) there is a significant up-regulation of Alpl in the BM-MSCs 475 
cultured onto PLLA-BBG-Sr membranes at 14 and 21 days of culture in relation to BM-476 
MSCs cultured onto PLLA membranes (all under osteogenic medium). Again, the Ren et 477 
al. found the same Alpl gene up regulated in MC3T3 cells cultured in PCL-SrBG 478 
membranes, but only after 21 days of culture. These observations are consistent with the 479 
quantification of the ALP activity (Figure 5b), in which there was a significantly higher 480 
activity for the BM-MSCs cultured onto PLLA-BBG-Sr (under osteogenic medium) after 481 
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14 days of culture, when compared with the cells cultured onto PLLA [47, 48]. Regarding 482 
the maturation and mineralization phase, we investigated the expression of the genes that 483 
encode two non-collagenous proteins present with the ECM of bone, e.g. Spp1 and Bglap. 484 
Spp1 is a protein found in bone, teeth, kidneys and epithelial lining tissue; consequently, 485 
Spp1 cannot be considered bone-specific, although it is associated to bone related 486 
functions [8, 45]. The Spp1 gene expression results (Figure 6b) showed that at 14 days 487 
of culture, BM-MSCs cultured on PLLA presents a high Spp1 expression, which might 488 
be related with their important functions in cell adhesion, migration and survival [53]. 489 
The fact that Spp1 expression is significantly higher when cultured on PLLA membranes 490 
might be a result of proliferation and cell spreading processes. On the other hand, Bglap, 491 
which is the second most abundant protein present in bone, is exclusively secreted by 492 
osteoblastic cells at the last stage of maturation [45, 53]. When cultured on PLLA-BBG-493 
Sr membranes, Bglap expression (Figure 6c) is significantly higher in relation to the basal 494 
medium for 14 and 21 days of culture. This suggests that the combined effect of the 495 
osteogenic factors and the dissolution products might be enhancing Bglap gene 496 
expression, which may be an indicator of osteoblastic differentiation. This data is in 497 
accordance with the report of Strobel et al. [54] showing that BM-MSCs, after 14 days of 498 
exposure to cell culture medium containing nanoparticles of Sr-substituted Bioglass, 499 
increased their  Bglap expression. Finally, Sp7 is a well-characterised osteoblast specific 500 
gene and it is associated with the regulation of numerous other genes (e.g. osteocalcin, 501 
osteopontin, bone sialoprotein), and is acknowledged as a late bone marker that plays a 502 
key role in the differentiation of preosteoblasts into fully functioning osteoblasts [8, 53]. 503 
Our data at day 21 registered an increase of Sp7 gene expression in the BM-MSCs 504 
cultured on PLLA-BBG-Sr membranes (under osteogenic medium) in relation to the 505 
same cells cultured on the same membranes but under basal medium, as well as the cells 506 
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cultured onto PLLA (under osteogenic and basal medium). These observations are 507 
consistent with the overexpression of the other monitored gene Alpl and their protein 508 
expression (ALP) for PLLA-BBG-Sr membrane [55]. In fact, Isaac et al. [56] 509 
demonstrated that the addition of strontium to bioactive glass particles resulted in a 510 
significant up-regulation of Runx2 and Osterix of osteoblastic cells. In summary, the 511 
detected overexpression of Alpl, Bglap and Sp7 genes in cells cultured onto PLLA-BBG-512 
Sr membranes show that the incorporation of BBG-Sr glass particles into the PLLA 513 
membranes promotes the osteogenic differentiation of BM-MSCs [47]. 514 
 515 
Figure 6. Relative gene expression profile of BM-MSCs cultured onto PLLA and PLLA-516 
BBG-Sr membranes during 14 and 21 days. Selected genes: Alpl, osteogenic 517 
mineralisation initiators (a); Spp1 (b) and Bglap (c), extracellular matrix; Sp7, 518 
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transcription factors. The transcripts’ expression data were normalized against the 519 
housekeeping gene Gapdh and the quantification performed according to the Livak 520 
method (2-ΔΔCt method). For each timepoint it was used: the calibrator PLLA (in basal 521 
medium) for the experiments with PLLA (in osteogenic medium); and the calibrator 522 
PLLA-BBG-Sr (in basal medium) for the experiments with PLLA-BBG-Sr (in osteogenic 523 
medium). In all the cases the calibrator is represented as a dashed line (threshold = 1). 524 
The results are expressed as mean ± standard deviation with n = 3 for each bar. The data 525 
was analysed by non-parametric statistics: Kruskal-Wallis test, followed by a Dunn’s 526 
Multiple Comparison test and differences were considered: *** p<0.001; ** p<0.01; and * 527 
p<0.05. a denotes significant differences in relation to cells cultured in basal medium (PLLA 528 
or PLLA-BBG-Sr); b denotes significant differences in relation to cell cultured onto PLLA 529 
in osteogenic medium. 530 
4. Conclusion 531 
Bioactive membranes of PLLA-BBG-Sr composites were successfully prepared using 532 
electrospinning. The µCT data evidenced that BBG-Sr microparticles were 533 
homogeneously incorporated into the fibres and the membrane structure. Our data 534 
indicated that, the addition of BBG-Sr into the PLLA matrix improved the in vitro water 535 
uptake and degradability of the membranes. Moreover, the incorporation of the BBG-Sr 536 
microparticles improved the mechanical properties of the membranes, namely in their 537 
Young modulus and tensile strength. The in vitro biological evaluation confirmed that 538 
both PLLA and PLLA-BBG-Sr membranes are able to promote the attachment of BM-539 
MSCs, without any cytotoxic effects. Furthermore, the addition of BBG-Sr microparticles 540 
to the PLLA membranes increased the ALP activity (under osteogenic conditions), as 541 
well as the BM-MSCs osteogenic differentiation as shown by up-regulation of Alpl, Sp7 542 
and Bglap gene expression in vitro. The present work suggests that the composite of 543 
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PLLA membranes and BBG-Sr microparticles can be used as a strategy to prepare 544 
bioactive composite membranes for bone regeneration. 545 
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